Back to search

Belgium· BE-AMP-SAM505040-00

Palonosetron Sandoz 250 µg

A palonosetron product containing palonosetron hydrochloride, registered in Belgium by Sandoz. The same ATC class is registered in 18 of our 19 countries.

ATC A04AA05

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedPalonosetron Sandoz 250 µgATCA04AA05REGISTER NO.BE-AMP-SAM505040-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Palonosetron is registered in 18 of 19 countries.

Countries holding a registration under ATC A04AA05 (palonosetron), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 10 of them publish a price we can compare per daily dose

Palonosetron · ATC A04AA05

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of palonosetron costs, country by country.

Normalised to the WHO defined daily dose (0.5 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Palonosetron · price per daily dose (0.5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$124.11
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Palonosetron Hydrochloride
Manufacturer
Sandoz
Country
Belgium (BE)
ATC code
A04AA05
ATC class
Palonosetron
Defined daily dose
0.5 mg, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    7720030
  • be_apb
    3573326

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

490 interactions on record for palonosetron.

Graded by severity as the source publishes them — 139 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Palonosetron · interactions on record

490 records

  • 139 severe
  • 195 moderate
  • 3 minor
  • 153 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • FenfluramineA08AA02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Palonosetron in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All palonosetron products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Palonosetron Kalceks
  • Bulgaria · Ферант
  • Cyprus · Ferant, Injosetron
  • Czechia · Ferant, Palonosetron Fresenius Kabi
  • Germany · Palonosetron Beta, Palonosetron Fresenius Kabi
  • Denmark · Palonosetron Kalceks, Palonosetron Macure
  • Estonia · Ferant, Palonosetron Kalceks
  • Spain · Ferant, Palonosetrón Qilu
  • Finland · Palonosetron Fresenius Kabi, Palonosetron Macure
  • France · Palonosetron Kalceks, Palonosetron Reig Jofre
  • United Kingdom (Northern Ireland) · Palonosetron Fresenius Kabi, Palonosetron Hydrochloride Qilu Pharma Spain
  • Greece · Ferant, Injosetron
  • Croatia · Ferant, Palonozetron Kalceks
  • Hungary · Palonosetron Kalceks, Palonosetron Onkogen
  • Ireland · Palonosetron
  • Iceland · Aloxi, Palonosetron Accord
  • Italy · Palonosetron Dr. Reddy’s, Palonosetron Fresenius Kabi
  • Liechtenstein · Aloxi, Palonosetron Accord
  • Lithuania · Ferant
  • Latvia · Ferant, Palonosetron Kalceks
  • Malta · Ferant, Palonosetron Anfarm
  • Netherlands · Palonosetron Fresenius Kabi
  • Norway · Aloxi, Palonosetron Accord
  • Portugal · Ferant, Palanossetrom Fresenius Kabi
  • Romania · Ferant, Palonosetron Dr. Reddy’s
  • Sweden · Ferant, Palonosetron Fresenius Kabi
  • Slovenia · Ferant, Palonosetron Fresenius Kabi
  • Slovakia · Ferant, Palonosetron Fresenius Kabi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8d474f73-fd9a-4f79-a8bb-0fa323b6491a
GET /v1/drugs/8d474f73-fd9a-4f79-a8bb-0fa323b6491a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Palonosetron Sandoz 250 µg",
  "name_fr": "Palonosetron Sandoz 250 µg",
  "name_nl": "Palonosetron Sandoz 250 µg",
  "amp_code": "SAM505040-00",
  "strengths": [
    "0.0560",
    "0.0560",
    "0.0500",
    "0.0500"
  ],
  "pack_count": 4,
  "substances": [
    "Palonosetron Hydrochloride",
    "Palonosetron"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Palonosetron",
  "authorisation_numbers": [
    "BE505040"
  ]
}

See everything about palonosetron.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.